Privi Speciality Chemicals Ltd

SBI Mutual Fund has sold 18,400 shares of Privi Speciality Chemicals Ltd, representing a 0.0471% stake. The transaction resulted in a decrease of approximately 2% in their overall holding. Prior to the sale, SBI Mutual Fund held 9.3765% of the company's paid-up share capital. After the sale, their holding stands at 7.3434%, amounting to 28,68,544 shares. The sale was conducted on the open market on September 24, 2026.

Privi Speciality Chemicals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2018, and the company's internal code of conduct. The window will be shut for all designated persons and their immediate relatives from October 01, 2026, until 48 hours after the declaration of the Un-audited Financial Results (Standalone and Consolidated) for the second quarter and half year ending September 30, 2026. This measure is to prevent insider trading during the period leading up to the financial results announcement.

Privi Speciality Chemicals Limited has announced a meeting of its equity shareholders, convened as per the order of the National Company Law Tribunal (NCLT), Mumbai Bench. The meeting, scheduled for October 27, 2026, via Video Conferencing (VC)/Other Audio-Visual Means (OAVM), will consider and approve the proposed Scheme of Amalgamation. This scheme involves the amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited. The notice and explanatory statement have been dispatched to shareholders, and remote e-voting will be open from October 22 to October 26, 2026.

Privi Speciality Chemicals Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors considered and approved these results, along with the Limited Review Reports from the Statutory Auditors, BSR & Co. LLP. The company made these results available on its website. The Board meeting commenced at 12:00 p.m. and concluded at 1:05 p.m. on July 30, 2026.

Privi Speciality Chemicals Ltd announced that its Board of Directors met on July 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has submitted the results along with the Limited Review Reports from its statutory auditors. These results are now available on the company's website. The board meeting commenced at 12:00 p.m. and concluded at 01:05 p.m.

Privi Speciality Chemicals Ltd has announced that its Board of Directors will convene on July 30, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The meeting will be held at the company's registered office in Navi Mumbai, with an option for video conferencing. The trading window for designated persons and their relatives, which closed on July 1, 2026, will reopen on August 3, 2026. The intimation is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Privi Speciality Chemicals Ltd has informed the stock exchanges about the dispatch of its Annual Report for the Financial Year 2025-26. This communication is in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 36(1)(b). The report, containing the exact web-link and path for access, has been sent to shareholders holding shares in physical form whose email addresses are not registered with the company's Registrar and Share Transfer Agent (RTA). The company also announced its 41st Annual General Meeting (AGM) scheduled for August 7, 2026, to be held via Video Conferencing. Shareholders are also reminded to update their KYC details as per SEBI mandates.

Privi Speciality Chemicals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This report, forming part of the Annual Report, details the company's commitment to sustainability and responsible business practices. The BRSR is available on the company's website and has been filed with the BSE and NSE. The report covers corporate identity, business activities, operational locations, markets served, and customer base, highlighting a significant export contribution of 66% to the total turnover. The company supplies aroma chemicals to major global fragrance and FMCG players.

Privi Speciality Chemicals Ltd has announced that its 41st Annual General Meeting (AGM) will be held on Friday, August 07, 2026, at 04:00 PM. The meeting will be conducted through Video Conferencing (VC) / other Audio-Visual Means (OAVM). The company will also be presenting the Annual Report for the Financial Year 2025-26. Remote e-voting will be open from August 04, 2026, to August 06, 2026. The Annual Report and Notice of AGM have been shared with shareholders via email and are also available on the company's website.

Privi Speciality Chemicals Ltd has announced its 40th Annual General Meeting (AGM) to be held on Friday, August 07, 2026, at 04:00 PM via video conferencing. The company has also released its Annual Report for the Financial Year 2025-26. Key details regarding remote e-voting, which will commence on August 04, 2026, and conclude on August 06, 2026, have been provided. The Annual Report and AGM notice are available on the company's website and have been sent to shareholders via email.